Biochemical Biomarker Combinations in Human Traumatic Spinal Cord Injury: An Exploratory Study.
6 affiliations
- 1Department of Neurosurgery, Aarhus University Hospital, Palle Juul-Jensens Boulevard 165, 8200 Aarhus N, Denmark.
- 2Department of Neurosurgery, The Neuroscience Centre, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark.
- 3Department of Clinical Medicine, Aarhus University, Palle Juul-Jensens Boulevard 82, 8200 Aarhus N, Denmark.
- 4Department of Anaesthesiology and Intensive Care, Aalborg University Hospital, Hospitalsbyen 1, 9260 Gistrup, Denmark.
- 5Department of Clinical Biochemistry, Aalborg University Hospital, Hospitalsbyen 1, 9260 Gistrup, Denmark.
- 6Department of Clinical Medicine, Aalborg University, Selma Lagerløfs Vej 249, 9260 Gistrup, Denmark.
Abstract
Background/Objectives: Early diagnosis and prognosis after traumatic spinal cord injury (TSCI) remain challenging, and single biochemical biomarkers have shown limited stand-alone utility. Combining different biomarkers may improve prediction. We explored combinations of biomarkers in blood and cerebrospinal fluid (CSF) and their association with injury severity and neurological outcome after TSCI. Methods: In this post hoc analysis of a previously reported prospective cohort, blood and CSF were collected from 15 patients with TSCI at a median of 13 h after injury. Biomarkers comprised 13 inflammatory/structural proteins measured by quantitative assays and an Olink Target 96 Inflammation panel (92 proteins). Injury severity was classified by the American Spinal Injury Association (ASIA) Motor Score (AMS) at admission (admission injury severity) and at follow-up (follow-up neurological status). LASSO regression with 1000 repetitions identified combinations associated with level-adjusted AMS. Results: Of the quantitative assay biomarkers, interferon-γ (IFN-γ), interleukin (IL)-6 and IL-8 in blood and IFN-γ and IL-10 in CSF were frequently selected for admission injury severity, while IL-6, IL-8 and glial fibrillary acidic protein (GFAP) in blood and IFN-γ in CSF were selected for follow-up neurological status. Olink panel biomarkers varied substantially: Thymic stromal lymphopoietin (TSLP), matrix metalloproteinase-10 (MMP-10) and IL-17A in blood and C-C motif chemokine 3 (CCL3) in CSF were selected in admission injury severity models, and CCL20 and TSLP in blood and CCL3 in CSF were selected for follow-up neurological status. Forcing admission injury severity into the follow-up models reduced internally cross-validated prediction error by approximately 29-33% across all panels, suggesting that much of the apparent biomarker signal reflected admission injury severity rather than independent prognostic information. Only GFAP in blood retained a consistent association with follow-up neurological status when accounting for admission injury severity. Conclusions: In this small exploratory study, blood-based combinations of IFN-γ, IL-8 and IL-6 and CSF-based combinations of IFN-γ and IL-10 were associated with admission injury severity. Only GFAP in blood showed consistent prognostic value beyond admission severity. Selection frequencies and cross-validated estimates are internal and hypothesis-generating, not evidence of clinical utility or generalizability; independent validation is required.
Related
- Integrated Multi-Omics Analysis of Human Cerebrospinal Fluid in Traumatic Spinal Cord Injury: An Exploratory Pilot Study.
- Predicting walking recovery after traumatic cervical spinal cord injury with machine learning: a multicenter cohort study
- Pathomic Texture Composites from H&E, and Immunohistochemistry of Prostatectomy Specimens for Exploratory Modeling of Time to Biochemical Recurrence
- Atomoxetine for Orthostatic Hypotension in Traumatic and Non-traumatic Spinal Cord Injury: A Case Series From a Neuro-Rehabilitation Setting.
- Be aware of the tuft of hair: traumatic lumbar intradural hematoma following spinal anesthesia in a case of occult spinal dysraphism. Illustrative case
BibTeX
@article{aagaard2026biochemical,
title = {{Biochemical Biomarker Combinations in Human Traumatic Spinal Cord Injury: An Exploratory Study.}},
author = {Kristoffer A Aagaard and Thea O Wichmann and Claus V B Hviid and Mikkel M Rasmussen},
journal = {Journal of clinical medicine},
year = {2026},
month = sep,
doi = {10.3390/jcm15197385},
url = {https://europepmc.org/article/MED/42881846},
note = {CC BY},
}
RIS
TY - JOUR
TI - Biochemical Biomarker Combinations in Human Traumatic Spinal Cord Injury: An Exploratory Study.
AU - Kristoffer A Aagaard
AU - Thea O Wichmann
AU - Claus V B Hviid
AU - Mikkel M Rasmussen
PY - 2026
DA - 2026/09/23
JO - Journal of clinical medicine
DO - 10.3390/jcm15197385
UR - https://europepmc.org/article/MED/42881846
AB - Background/Objectives: Early diagnosis and prognosis after traumatic spinal cord injury (TSCI) remain challenging, and single biochemical biomarkers have shown limited stand-alone utility. Combining different biomarkers may improve prediction. We explored combinations of biomarkers in blood and cerebrospinal fluid (CSF) and their association with injury severity and neurological outcome after TSCI. Methods: In this post hoc analysis of a previously reported prospective cohort, blood and CSF were collected from 15 patients with TSCI at a median of 13 h after injury. Biomarkers comprised 13 inflammatory/structural proteins measured by quantitative assays and an Olink Target 96 Inflammation panel (92 proteins). Injury severity was classified by the American Spinal Injury Association (ASIA) Motor Score (AMS) at admission (admission injury severity) and at follow-up (follow-up neurological status). LASSO regression with 1000 repetitions identified combinations associated with level-adjusted AMS. Results: Of the quantitative assay biomarkers, interferon-γ (IFN-γ), interleukin (IL)-6 and IL-8 in blood and IFN-γ and IL-10 in CSF were frequently selected for admission injury severity, while IL-6, IL-8 and glial fibrillary acidic protein (GFAP) in blood and IFN-γ in CSF were selected for follow-up neurological status. Olink panel biomarkers varied substantially: Thymic stromal lymphopoietin (TSLP), matrix metalloproteinase-10 (MMP-10) and IL-17A in blood and C-C motif chemokine 3 (CCL3) in CSF were selected in admission injury severity models, and CCL20 and TSLP in blood and CCL3 in CSF were selected for follow-up neurological status. Forcing admission injury severity into the follow-up models reduced internally cross-validated prediction error by approximately 29-33% across all panels, suggesting that much of the apparent biomarker signal reflected admission injury severity rather than independent prognostic information. Only GFAP in blood retained a consistent association with follow-up neurological status when accounting for admission injury severity. Conclusions: In this small exploratory study, blood-based combinations of IFN-γ, IL-8 and IL-6 and CSF-based combinations of IFN-γ and IL-10 were associated with admission injury severity. Only GFAP in blood showed consistent prognostic value beyond admission severity. Selection frequencies and cross-validated estimates are internal and hypothesis-generating, not evidence of clinical utility or generalizability; independent validation is required.
SN - 2077-0383
ER -